Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose

OBJECTIVE: Hydroxychloroquine (HCQ) has been prescribed in Japan only relatively recently and is recommended for the treatment of skin lesions, arthritis and renal lesions according to the Japanese Guideline for the Management of systemic lupus erythematosus (SLE) (2019). However, the associations b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakiya, Risa, Kameda, Tomohiro, Nakashima, Shusaku, Shimada, Hiromi, Fahmy Mansour, Mai Mahmoud, Kato, Mikiya, Miyagi, Taichi, Kadowaki, Norimitsu, Dobashi, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516317/
https://www.ncbi.nlm.nih.gov/pubmed/32522920
http://dx.doi.org/10.2169/internalmedicine.4317-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516317/
https://www.ncbi.nlm.nih.gov/pubmed/32522920
http://dx.doi.org/10.2169/internalmedicine.4317-19

Ejemplares similares